eIF5ACRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。eIF5A遺伝子サイレンサーは、eIF5A CRISPR/Cas9ノックアウトプラスミドとeIF5ADouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のeIF5ACRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
eIF5A CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
eIF5A CRISPR/Cas9 KOプラスミド (h) | sc-401820 | h | Gene Knockout | GFP | 0 | ||
eIF5A HDRプラスミド (h) | sc-401820-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
eIF5A Double Nickaseプラスミド (h) | sc-401820-NIC | h | Gene Knockout | Puromycin | 0 | ||
eIF5A Double Nickaseプラスミド (h2) | sc-401820-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
eIF5A CRISPR/Cas9 KOプラスミド (m) | sc-435476 | m | Gene Knockout | GFP | 0 | ||
eIF5A HDRプラスミド (m) | sc-435476-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
eIF5A Double Nickaseプラスミド (m) | sc-435476-NIC | m | Gene Knockout | Puromycin | 0 | ||
eIF5A Double Nickaseプラスミド (m2) | sc-435476-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
eIF5A2 CRISPR/Cas9 KOプラスミド (h) | sc-416430 | h | Gene Knockout | GFP | 0 | ||
eIF5A2 HDRプラスミド (h) | sc-416430-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
eIF5A2 Double Nickaseプラスミド (h) | sc-416430-NIC | h | Gene Knockout | Puromycin | 0 | ||
eIF5A2 Double Nickaseプラスミド (h2) | sc-416430-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
eIF5A2 CRISPR/Cas9 KOプラスミド (m) | sc-431583 | m | Gene Knockout | GFP | 0 | ||
eIF5A2 HDRプラスミド (m) | sc-431583-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
eIF5A2 Double Nickaseプラスミド (m) | sc-431583-NIC | m | Gene Knockout | Puromycin | 0 | ||
eIF5A2 Double Nickaseプラスミド (m2) | sc-431583-NIC-2 | m | Gene Knockout | Puromycin | 0 |
eIF5A CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
eIF5A CRISPR Activationプラスミド (h) | sc-401820-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A CRISPR Activationプラスミド (h2) | sc-401820-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A Lentiviral Activation Particles (h) | sc-401820-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A Lentiviral Activation Particles (h2) | sc-401820-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A CRISPR Activationプラスミド (m) | sc-435476-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A CRISPR Activationプラスミド (m2) | sc-435476-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A Lentiviral Activation Particles (m) | sc-435476-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A Lentiviral Activation Particles (m2) | sc-435476-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 CRISPR Activationプラスミド (h) | sc-416430-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 CRISPR Activationプラスミド (h2) | sc-416430-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 Lentiviral Activation Particles (h) | sc-416430-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 Lentiviral Activation Particles (h2) | sc-416430-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 CRISPR Activationプラスミド (m) | sc-431583-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 CRISPR Activationプラスミド (m2) | sc-431583-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 Lentiviral Activation Particles (m) | sc-431583-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
eIF5A2 Lentiviral Activation Particles (m2) | sc-431583-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |